This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,137,500
Toward clinical translation of retinal gene therapy for Zellweger Spectrum Disorder
CIHR · 2024 · Principal investigator
Toward clinical translation of retinal gene therapy for Zellweger Spectrum Disorder
CIHR · 2023 · Principal investigator
Toward clinical translation of retinal gene therapy for Zellweger Spectrum Disorder
Principal investigators: Braverman, Nancy E; Koenekoop, Robert K; Benson, Matthew D
Keywords: Aav Manufacturing; Cta Enabling Studies; Mouse Safety Studies; Peroxisome Disorder; Retinal Gene Therapy
Toward clinical translation of retinal gene therapy for Zellweger Spectrum Disorder
Principal investigators: Braverman, Nancy E; Koenekoop, Robert K; Benson, Matthew D
Keywords: Aav Manufacturing; Cta Enabling Studies; Mouse Safety Studies; Peroxisome Disorder; Retinal Gene Therapy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.